Compare Kraft Heinz Co (KHC) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kraft Heinz Co vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Kraft Heinz Co trades at $22.27 (market cap $26.66B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Kraft Heinz Co and Royalty Pharma plc Class A Ordinary Shares are close in size by market cap, and Kraft Heinz Co pays the higher dividend (7.12%). Which is the better fit depends on your goals — on Pluang, investors hold Kraft Heinz Co for 129 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| KHC | RPRX | |
|---|---|---|
Market Cap | $26.66B | $25.27B |
Volume | 31,300,109 | 3,671,183 |
Sector | Consumer Staples | Health |
52-Week High | $27.62 | $63.96 |
52-Week Low | $21.21 | $35.44 |
Typical Hold Time | 129 Days | 1 Days |
Enterprise Value | $42.98B | $32.50B |
Dividend Yield | 7.12% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kraft Heinz (KHC) trades at $22.48, up 2.27% on the day, with a bearish technical signal and mixed fundamentals. The stock shows a low P/E of 13.04 and P/B of 0.74, but negative net income and ROE reflect profitability challenges. Recent earnings have beaten estimates, and the company maintains a $0.40 dividend. Cash flow improved in 2025, though revenue declined to $24.94 billion. News highlights turnaround efforts, including new product launches and a halted breakup plan.
The outlook is cautious; while valuation appears cheap and dividends attract income investors, persistent negative margins and high debt pose risks. Analyst consensus is mixed with a $24.50 price target, but bearish sentiment and competitive pressures suggest limited near-term upside. Investors should weigh the dividend yield against execution risks in the consumer goods sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
